AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
PeerRishi Sekar, MD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerEgbert Smit, MD
PeerCholangiocarcinoma: Treatment with Targeted Therapies
Advancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Rami Komrokji, MD
PeerNavigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC